We found that small tumour size (<6 cm)/high-moderate differentiation/TNM early stage (I-II) patients with INPP4B+ had a more favourable prognosis than patients with INPP4B- (Figure 2H), whereas large tumour size (≥ 6cm)/low-undifferentiated/TNM advanced stage (III-IV) patients with INPP4B+ had a worse prognosis than patients with INPP4B- (Figure 2I). The gene discussed is INPP4B; the disease is neoplasm.